Back to Test Catalogue

Women’s Health and Breast Profile, Saliva

Test ID: WHBPANEL
Orderable by Ontario ND

Test

Report Includes

Estradiol (E2); Estriol; Estrone; Estrogen Quotient; Progesterone (PG); PG/E2 Ratio; Testosterone; DHEA; Cortisol x 4

Specimens

Saliva

Clinical Utility

TheWomens Health and Breast Profileincludes two risk assessment ratios, the Estrogen Quotient and the Pg/E2 ratio. Dr. Henry Lemon developed the Estrogen Quotient (EQ) which is a simple ratio of the cancer protective E3 to the proliferative estrogens E1 and E2. According to Dr. Lemon, the EQ provides an assessment of breast cancer risk, with a lower number (<1.0) indicating increased risk, and a higher number (>1.0) signifying a lower risk. Dr. Lemons work stated that for maximum protection, an optimal EQ is >1.5. The Pg/E2 ratio, developed by Dr. John Lee, illuminates the relationship between estradiol, which is a proliferative hormone, and progesterone, which balances estradiol and slows cellular proliferation. The information gained from this profile will help to further the conversation with your patients about targeted treatment options such as BHRT, nutraceutical and herbal supplementation, as well as potential lifestyle modifications.

Source: https://www.labrix.com/SalivaTestingMenu;Accessed 27-Aug-2019.

Test Location

Doctor's Data, IL, USA

Test Version

9-May-2022

Specimen

Specimens

Saliva

Additional Information

A specimen collection kit is available. To order a kit online, please register or login. For assistance or more information, please click here to send us an email or call 416-422-3000 x 300.

Stability

Refrigerated 10 Days
Frozen 21 Days

Test Version

9-May-2022

Performance / Interpretation

Turnaround Time

8 Days

Sample Reports

Sample Report at external website.

Test Location

Doctor's Data, IL, USA

Test Version

9-May-2022

Interface / Setup

Sample Reports

Sample Report at external website.

Test Version

9-May-2022